CARL Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 -1.22%, SMA50 -3.1%, SMA200 -5.41%). The stock’s 14-day RSI is 47.45 (neutral), while the ATR of 0.85 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -26.18% below its high and over 10.83% above its low. Average 10-day trading volume of 60.83 thousand shares is below the 3-month average of 68.07 thousand, indicating normal recent market interest.

CARLSMED, INC. has 26.52 million shares outstanding. The public float is 9.70 million shares, elevated short interest at 1.97% of float. This equals 151.59 thousand shares. The short ratio is 1.19 days. Institutional investors hold 0.94% of the float. Insiders own 42.08%.

Analyst sentiment is bullish. Analyst rating data shows there are 1 Strong Buy ratings, 5 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $24.00 to $18.00. The high target offers 89.13% upside. The low target suggests 41.84% downside. The mean target is $20.50. This offers 61.54% upside. CARLSMED, INC. earnings surprise history is a mixed track record. The quarter that ended November 06, 2025, missed forecasts by -11.11%. The prior quarter beat by -3.29%. Over the last six quarters, Apple has recorded several small beats. These include -3.29% in August 28, 2025.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

CARLSMED, INC. (NASDAQ:CARL) closed at $12.69 USD, losing -$0.18 (-1.40%) from the previous close of $12.87. The stock is currently mid-range between its 52-week high and low $11.45 and $17.19. With a market capitalization of about $337.46 million, CARLSMED, INC. is classified as a small-cap and shows lower-than-market volatility (beta ~-0.21). Key stats such as the average daily volume over the past year has been around 68.23 thousand shares, volume is running light vs its 52-week average. Headquartered in Carlsbad, CA, CARLSMED, INC. operates in the Healthcare sector and the Medical - Healthcare Information Services industry. Led by CEO Michael John Cordonnier, the company employs approximately 100 people and listed since April 05, 2018. Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to harness clinical intelligence, advanced image recognition, and 3D printing technologies.

Our AI price prediction model suggests that CARLSMED, INC. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

currently trading near 52-week highs band. Valuation shows CARLSMED, INC. trading at a premium to the broader market with a P/E of -10.39. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $20.50, suggesting 61.54% upside.

CARLSMED, INC. trades at a P/E ratio of -10.39, slightly below the S&P 500 average, with a price-to-sales ratio of 7.54 and a price-to-book ratio of 2.51 suggesting the stock is closer to book value. The P/FCF stands at -11.62, also below market averages.